Alembic Pharmaceuticals Limited (APLLTD) receives final approval from USFDA for Tretinoin Cream USP, 0.05%, with an estimated market size of US$ 76 million.
Suven Life Sciences Limited (SUVEN) announces three poster presentations on Samelisant at SLEEP-2026 Annual Meeting in Baltimore, showcasing clinical advance.
Emcure Pharmaceuticals Limited (EMCURE) reports strong FY26 results with revenue up 16.6% and margin expansion, driven by robust international performance.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA tentative approval for Larotrectinib Capsules, marking a significant milestone.
Glenmark Pharmaceuticals Limited (GLENMARK) launches Winlevi® cream in key European markets, marking first NCE launch and strengthening dermatology portfolio.
Panacea Biotec Limited (NSE: PANACEABIO) launches DE NSTAR project to advance dengue vaccine DengiA/1 licensure in Sub-Saharan Africa.
Viyash Scientific Limited (VIYASH) acquires Italy's BioForLife, boosting its European companion animal health market presence.
Lupin Limited partners with LABORATORIOS ERN S.A. to launch Luforbec® in Spain, expanding respiratory care access.
Alembic Pharmaceuticals Limited (NSE: APLLTD) secures USFDA final approval for Haloperidol Tablets, expanding its generic drug portfolio.
Aurobindo Pharma Limited (AUROPHARMA) secures final approval from US FDA for Tofacitinib Tablets, targeting a US$494 million market.